APA (7th ed.) Citation

Chioncel, O., Mebazaa, A., Farmakis, D., Abdelhamid, M., Lund, L. H., Harjola, V., . . . Jankowska, E. (2025). Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Journal of Heart Failure, 27(6), 1067. https://doi.org/10.1002/ejhf.3673

Chicago Style (17th ed.) Citation

Chioncel, Ovidiu, et al. "Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)." European Journal of Heart Failure 27, no. 6 (2025): 1067. https://doi.org/10.1002/ejhf.3673.

MLA (9th ed.) Citation

Chioncel, Ovidiu, et al. "Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)." European Journal of Heart Failure, vol. 27, no. 6, 2025, p. 1067, https://doi.org/10.1002/ejhf.3673.